2024 was a monumental year for HeartLung Technologies. With that being said, we have exciting developments for 2025!

Experts in pulmonary medicine stress the early detection of lung diseases, low-dose CT scans, and the role of pulmonologists in patient care

Dr. Metersky stresses the importance of early bronchiectasis diagnosis and treatment, noting the benefits of low-dose CT scans and more.

Dr. Maria Padilla, MD, stresses early ILD diagnosis, highlighting low-dose CT scans for better outcomes and new therapeutic interventions.

Dr. Rizzo stresses the need for early COPD detection, clear guidelines, and the role of pulmonologists and new drugs in improving outcomes.

Dr. Mulshine highlights early detection's role in preventing thoracic disease deaths, advocating for screening effectiveness over quantity.

Experts discuss integrating lung cancer screening with cardiovascular prevention using AI and low-dose CT scans to enhance early detection.

Dr. Sharma stresses the need for early detection and transcatheter procedures for valvular heart disease, noting higher prevalence in women.

Dr. Reddy highlights AF's rising prevalence and risks, stressing early detection and anticoagulation to reduce stroke in high-risk patients.

Dr. Sean Pinney stresses the importance of early detection of heart failure, noting disparities and the role of AI-enhanced screening tools.

Dr. Ahmadi highlights the need for early detection and treatment of atherosclerosis with advanced imaging and AI to prevent heart attacks.

Dr. Mehran highlights the shift to prevention in cardiology, stressing optimized stent placement, personalized regimens, and LDL-lowering.

Dr. David Yankelevitz highlights the integration of lung cancer screening with cardiology, emphasizing AI's role in preventive health.

Dr. Claudia Henschke highlights 30 years of progress in lung cancer screening, sharing milestones and future goals for improved outcomes.

Dr. Morteza Naghavi gave an introductory presentation at the 1st Conference on Integrating Early Detection of Heart and Lung Disease

Dr. Robert Harrington urges early cardiovascular risk detection, public health measures, and policy reforms to combat rising disease rates.

Dr. Claudia Henschke, Dr. Morteza Naghavi, and Dr. David Yankelevitz gave a warm welcome and introductory presentations.

HeartLung collaborator, Dr. Claudia Henschke, has been honored with the prestigious Scientific Excellence Award at #RSNA2024!

HeartLung is the only AI company participating in RSNA 2024 as a scientific presenter of research studies and as an industry exhibitor

Innovative AI-enabled research studies led by HeartLung’s founder Dr. Morteza Naghavi show life-saving potential for primary prevention...